After winning U.S. Department of Agriculture approval in 2013, the genetically engineered pink pineapple from Del Monte Fresh Produce now has passed muster at the Food and Drug Administration.

The FDA said in a mid-December  release that there are no unresolved regulatory or safety questions for the fruit.

A spokesperson for Del Monte could not be reached for comment; in a 2013 statement, the company said the variety — dubbed Rosé — was in a testing phase. Del Monte is working with the government of Costa Rica on its production plans, according to the FDA.

Coral Gables, Fla.-based Del Monte submitted information to the FDA to demonstrate that the pink flesh pineapple is as safe and nutritious as its conventional counterparts, according to the release.

The pineapple has been genetically engineered to produce lower levels of the enzymes already in conventional pineapples that convert the pink pigment lycopene to the yellow pigment beta carotene.  Lycopene is the pigment that makes tomatoes red and watermelons pink.

According to the FDA’s release, Del Monte plans to identify it as an “extra sweet pink flesh pineapple” on tags attached to the crown of the fruit to distinguish the pink-flesh pineapple from Del Monte’s “golden” pineapples.

Other companies interested in marketing the pink-flesh pineapple are advised to consult with FDA’s Center for Food Safety and Applied Nutrition’s Office of Nutrition and Food Labeling, according to the release.

Del Monte voluntarily submitted the pink pineapple for FDAs review, which allows marketers to make sure that derived from new plant varieties are safe and comply with the FDA regulations, according to the release.